REQUEST A DEMO
Total
USD $0.00
Search more companies

Biopharmalab S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Biopharmalab S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Biopharmalab S.A.S. is an enterprise based in Ecuador. Its main office is in Eloy Alfaro. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on October 18, 2022. Biopharmalab S.A.S. currently employs 2 (2024) people. There was a net sales revenue increase of 17.87% reported in Biopharmalab S.A.S.’s latest financial highlights for 2024. A negative growth of 18.56% was recorded in its total assets. The net profit margin of Biopharmalab S.A.S. increased by 1.75% in 2024.

Headquarters
Via Duran Tambo, 2
Eloy Alfaro; Guayas;

Contact Details: Purchase the Biopharmalab S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Biopharmalab S.A.S. report to view the information.
Registered Capital:
Purchase the Biopharmalab S.A.S. report to view the information.
Financial Auditors:
Purchase the Biopharmalab S.A.S. report to view the information.
Incorporation Date:
October 18, 2022
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Biopharmalab S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.87%
Total operating revenue
17.87%
Operating profit (EBIT)
137.83%
EBITDA
137.83%
Net Profit (Loss) for the Period
139.63%
Total Assets
-18.56%
Total Equity
218.83%
Operating Profit Margin (ROS)
2.74%
Net Profit Margin
1.75%
Return on Equity (ROE)
-22.68%
Quick Ratio
0.88%
Cash Ratio
0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?